Vyome Holdings, Inc. Market Cap ($12.42 Million)
Market Cap & Net Worth: Vyome Holdings, Inc. (HIND)
Vyome Holdings, Inc. market cap. Vyome Holdings, Inc. (NASDAQ:HIND) has a market capitalization of $12.42 Million ($12.42 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26357 globally and #5522 in its home market, demonstrating a 3.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vyome Holdings, Inc.'s stock price $1.77 by its total outstanding shares 7018528 (7.02 Million). Also see cash flow conversion of Vyome Holdings, Inc. for how efficiently the company converts equity into cash flow.
Vyome Holdings, Inc. Market Cap History (2025–2026)
Vyome Holdings, Inc. market cap history from 2025 to 2026. Data shows growth from $24.14 Million to $12.42 Million (0.00% CAGR). Check Vyome Holdings, Inc. (HIND) stock price for real-time trading data and today's change.
Vyome Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vyome Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Vyome Holdings, Inc. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
75.52x
Vyome Holdings, Inc.'s market cap is 75.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $24.14 Million | $319.71K | -$10.26 Million | 75.52x | N/A |
Competitor Companies of HIND by Market Capitalization
Companies near Vyome Holdings, Inc. in the global market cap rankings as of November 4, 2026. Also see HIND asset base for a full breakdown of the balance sheet.
Key companies related to Vyome Holdings, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Vyome Holdings, Inc. (2025–2026)
Market capitalization of Vyome Holdings, Inc. from 2025 to today. Between 2025 and today, Vyome Holdings, Inc.'s market cap moved from $24.14 Million to $ 12.42 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $12.42 Million | -48.55% |
| 2025 | $24.14 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vyome Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.42 Million USD |
| MoneyControl | $12.42 Million USD |
| MarketWatch | $12.42 Million USD |
| marketcap.company | $12.42 Million USD |
| Reuters | $12.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vyome Holdings, Inc.
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinica… Read more